Bupivacaine Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00297 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 22 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | acrodermatitis chronica atrophicans | KG + DL |
| 2 | neonatal dermatomyositis | KG + DL |
| 3 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 4 | amyopathic dermatomyositis | KG + DL |
| 5 | acne keloid | KG + DL |
| 6 | hydroa vacciniforme, familial | KG + DL |
| 7 | uterine polyp | KG + DL |
| 8 | epulis | KG + DL |
| 9 | polyp of vocal cord | KG + DL |
| 10 | polyp of middle ear | KG + DL |
| 11 | fibroepithelial polyp | KG + DL |
| 12 | polyp of ureter | KG + DL |
| 13 | polyp of frontal sinus | KG + DL |
| 14 | neoplastic polyp | KG + DL |
| 15 | polyp of vulva | KG + DL |
| 16 | polyp of external auditory canal | KG + DL |
| 17 | papillary conjunctivitis | KG + DL |
| 18 | bronchitis | KG + DL |
| 19 | nasal cavity polyp | KG + DL |
| 20 | seborrheic dermatitis | KG + DL |
| 21 | gastroduodenitis | KG + DL |
| 22 | atopic eczema | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.